Soon after their arrival in Australia, the Pasteur Mission was contacted by Arthur Devlin, a grazier who owned several properties that were affected by a sheep disease known as Cumberland Disease. They agreed to look into this matter while they were in Australia, and within a couple of months the Pasteur Mission announced that they had successfully made a culture of Bacillus Anthracis from the blood of a sheep that had died of Cumberland Disease. As a result of this, it was proposed to proceed to a trial of Pasteur's Anthrax Vaccine.
![]() |
The trial was held under the supervision of two graziers and three government officials at Junee Junction during September and October 1888. The trial was undertaken on thirty-nine sheep and six head of cattle. It was a complete success: all vaccinated animals remained in very good health, whereas all nineteen unprotected sheep and one of the two non-vaccinated cows died within a few days.
The success of the Anthrax Vaccine trial prompted the Government to offer Loir a laboratory and assistants to manufacture the vaccine, which would then be sold to graziers. It was some time, however, before this proposition led to concrete results. |
Picture Reference
Cover illustration from Loir, Adrien, Pasteur's Vaccine of Anthrax in Australia: as a preventative against Cumberland Disease in sheep, cattle and horses, published c.1891, Sydney, held in National Library of Australia, Canberra.